23
Participants
Start Date
September 22, 2017
Primary Completion Date
December 17, 2018
Study Completion Date
December 17, 2019
Oxytocin nasal spray
Self administered Oxytocin nasal spray q.i.d. for 8 weeks versus placebo (normal saline nasal spray)
Placebo nasal spray
Self administered Placebo nasal spray q.i.d. for 8 weeks (normal saline nasal spray)
Texas Diabetic Institute, San Antonio
The University of Texas Health Science Center at San Antonio
OTHER
The University of Texas Health Science Center, Houston
OTHER
The University of Texas Medical Branch, Galveston
OTHER
Sara Espinoza
OTHER